← Leaderboards
Andrew Levin
Immunetics, Inc.
$3,885,139
Attributed
$3,885,139
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2010–12$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
Funding mix
By agency
NIH$3,885,139 · 2
By mechanism
N44$3,667,660 · 1
N43$217,479 · 1
Top collaborators
No co-investigators on record.
Most similar at Immunetics, Inc.
Same institution · by research overlap
- Andrew E. Levin$41,764,391
- Victor A Kovalenko$2,509,312
- Neil X Krueger$5,735,933
Others in their field
Top investigators on “Blood Screening”
- David R. Weir · University Of Michigan At Ann Arbor$233,455,195
- Stephen S. Rich · University Of Alabama At Birmingham$62,168,485
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,225,704
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$45,006,168
- Loic Le Marchand · University Of Hawaii At Manoa$40,708,966
- Ralph Weissleder · Massachusetts General Hospital$37,171,170
Research focus
Blood ScreeningBabesiaBabesiosisBorrelia MicrotiCessation Of LifeElderlyEnzyme ImmunoassayErythrocytesImmunosuppressedInfectionMalariaParasitesPrototypeReportingSensitivity And SpecificityTransfusionUnited StatesPreparationPreventEnzyme-Linked Immunosorbent AssaySerologicalEvaluationFda ApprovedFollow-Up